Praeventix LLC
Exton, PA Doing business as Praeventix LLC
- UEI
- NLSMGTKWQR16
- CAGE
- 7J3K3
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 665 Stockton Dr #200h, Exton, PA 19341, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| In vivo characterization of 5-HT7 modulators in RAT models of opioid use disorder - opioid analgesics (e.g. Fentanyl,… | National Institute on Drug Abuse | $355,190 | |
| IND enabling studies for the development of pruritus therapeutic PRA-523 - project summary (abstract) pruritus, the urge… | National Insititue of Arthritis and Musculoskeletal and Skin Diseases | $3,217,535 | |
| Novel 5-HT7 antagonists for the treatment of pruritus - project summary (abstract) evidence supporting serotonin… | National Insititue of Arthritis and Musculoskeletal and Skin Diseases | $547,696 | |
| In vivo characterization of 5-HT7 modulators in RAT models of cocaine use disorder - cocaine is one of the most commonly… | National Institute on Drug Abuse | $6,570,000 | |
| In vivo characterization of PRA078C in the RAT cocaine reinstatement model | National Institute on Drug Abuse | $350,000 |
About Praeventix LLC
Praeventix LLC, a for-profit biopharmaceutical company based in Exton, Pennsylvania, operates exclusively as a federal grant recipient conducting preclinical pharmacology research for the National Institutes of Health, with no federal contract experience.
The company's seven federal grants—all prime awards with no subcontract engagement—total $13.7 million obligated across three NIH institutes. Work centers on drug discovery and development for substance use disorders and dermatological conditions, grounded in 5-HT7 receptor antagonist and modulator chemistry. The National Institute on Drug Abuse (NIDA) funds two active grants: a $355,190 Project Grant (CFDA 93.279, award date June 1, 2026, ultimate completion May 31, 2027) for in vivo characterization studies of the lead compound PRA078 in rat models of opioid use disorder, evaluating dopamine pathway regulation and cognitive flexibility improvements relevant to withdrawal and depression; and an earlier grant (award date June 1, 2022, ultimate completion May 31, 2026) for in vivo characterization of 5-HT7 modulators in rat models of cocaine use disorder, testing cognitive flexibility and extinction learning as treatment targets for cocaine use disorder. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) granted two awards, both completed or completing in 2023–2025: a Project Grant for novel 5-HT7 antagonists targeting chronic pruritus in atopic dermatitis (ultimate completion August 31, 2023) and an IND-enabling study for the pruritus therapeutic PRA-523 (ultimate completion August 31, 2025). The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) accounts for two additional awards in the source portfolio, with details not fully rendered in the source material.
Customer concentration is total with HHS–NIH: 100% of awards across three institutes, with NIDA and NIAMSD as the primary funders. Activity shows a sparse pattern—two awards in 2017, one in 2019, three in 2022, and one in 2026—characteristic of early-stage biotech pursuing grant-based preclinical research. One award faces ultimate completion within the next twenty-four months, representing minimal near-term recompete exposure. The company has not competed for or held federal contracts, IDIQs, GWACs, or BPAs.
Quick answers
What is Praeventix LLC's UEI?
Praeventix LLC's Unique Entity ID (UEI) in SAM.gov is NLSMGTKWQR16.
What is Praeventix LLC's CAGE code?
Praeventix LLC's CAGE code is 7J3K3.
Where is Praeventix LLC located?
Praeventix LLC's physical address in SAM.gov is 665 Stockton Dr #200h, Exton, PA 19341, USA.
Is Praeventix LLC registered in SAM.gov?
Yes. Praeventix LLC's SAM.gov registration is active through January 29, 2027.
What is Praeventix LLC's most recent federal award?
Praeventix LLC's most recent federal grant award is In vivo characterization of 5-HT7 modulators in RAT models of opioid use disorder - opioid analgesics (e.g. Fentanyl,… (R43DA064569), from National Institute on Drug Abuse, on June 1, 2026.
On GovTribe
See Praeventix LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors